TrenibotE Could Provide a Rapid-Onset Botox Alternative
December 5, 2025 | ABCS
A recent development in Botox-type injectables is TrenibotE (trenibotulinumtoxinE), a novel neuromodulator from AbbVie—the pharmaceutical company behind Allergan Aesthetics and Botox® Cosmetic. AbbVie is currently seeking FDA approval for TrenibotE to treat moderate to severe glabellar lines, commonly known as frown lines or “11s” between the eyebrows. What makes TrenibotE… Read More »








